|
|
|
|
Efficient drug development, manufacturing, and supply are essential for transforming innovation into therapeutic and commercial success. Yet, increasing industry complexity and risk are reshaping outsourcing models. To navigate ongoing uncertainties and disruptions, companies need to carefully structure and manage CDMO partnerships.
|
|
|
|
|
Companies looking to increase cost efficiencies have various considerations to incorporate, including decision-making around effective project management, partnerships strategy, and developing sustainable processes. Learn how outsourcing helps to achieve success in all these areas, which combine to increase cost efficiency.
|
|
|
|
|
Sponsors spend considerable time and resources on process development and validation to create a launch-ready manufacturing process, which might require minor refinement. More often, however, significant process refinement is needed when adding additional CDMOs in preparation for process validation and commercial launch.
|
|
|
|
|
|
|
|
|
|
|
